Nova Leap Health (NLH) investor relations material

Investment case and industry trends

• Operates in home-based and community-based care, benefiting from strong demographic trends as the population ages, especially with 12,000 Americans turning 65 daily.

• Market is highly fragmented, offering significant consolidation opportunities through acquisitions of smaller, often family-owned businesses.

• Management and directors own over 42% of shares, aligning interests with shareholders.

• Record revenue and EBITDA, with positive operating and net cash flow since 2024.

• Focus on disciplined capital allocation, funding growth through debt and cash flow without equity dilution since 2022.

Financial performance and capital structure

• Trailing 12-month revenue as of Q1 2026 was CAD 32 million, with adjusted EBITDA of CAD 2.2 million.

• Recent acquisition in Nova Scotia added CAD 3.8 million in revenue and CAD 785,000 in EBITDA for 2025.

• Maintains strong liquidity, with $1.6 million in cash at March 2026 and $3 million in acquisition capacity.

• Leverage ratio was 0.88x at Q1 2026, remaining strong post-acquisition.

• Market cap is approximately $25 million (CAD 32 million).

Growth strategy and operational model

• Growth strategy centers on organic growth, service line expansion, and acquisitions.

• Organic growth focuses on increasing service hours, deepening referral relationships, and opening new offices within existing regions.

• Service line expansion includes care management and palliative care launched in early 2026, with private nursing under review for 2027.

• Acquisition strategy targets operationally straightforward, financially accretive businesses at 3-5x EBITDA, enhancing market density.

• Shared services platform centralizes functions like billing, payroll, and compliance, driving operating leverage and margin improvement.